Deals this week: TransEnterix, Ugentec, Bone Biologics

6 April 2018 (Last Updated April 6th, 2018 10:23)

TransEnterix plans to raise funds through a public offering of 2.5 million shares of its common stock.

TransEnterix plans to raise funds through a public offering of 2.5 million shares of its common stock.

The selling shareholders will offer and sell shares from time to time once the registration statement comes into effect.

Based in the US, TransEnterix is focused on the use of robotics to improve minimally invasive surgery.

Ugentec NV has raised €7.5m ($9.3m) through a series A financing round led by existing shareholders and investors.

Based in Belgium, Ugentec has developed an artificial intelligence (AI) driven polymerase chain reaction (PCR) analysis and workflow software.

Ugentec plans to use the funds to strengthen its position in clinical diagnostics, set up an office in the US, and expand its business into new markets.

Bone Biologics Corporation has raised $0.5m through a second tranche of private placement subscribed to by Orthofix Holding Inc.

The company has raised $1.4m in total from its previous offerings.

Based in the US, Bone Biologics is a developer and marketer of orthobiologic products.

Inari Medical Inc has raised $27m through a series C financing round led by Gilde Healthcare Partners BV along with participation from existing investors Versant Ventures and US Venture Partners.

“The simulation systems will enable the company to develop a surgeon training programme for the surgical system.”

Based in the US, Inari Medical is focused on the development of innovative catheter-based technologies.

The company plans to use the funds to support the commercialisation of its catheter-based technologies designed for the treatment of venous thromboembolism (VTE).

Medicrea Group has signed an agreement with Motion Medical Inc to form a joint venture named Medicrea Belgium to launch its products and technologies in the Belgian market.

Medicrea International will hold 51% stake in the newly formed JV, with plans to make the JV a fully owned subsidiary in the future.

Based in France, Medicrea Group is a medical equipment company, while Motion Medical is a US-based supplier of medical equipment.

Titan Medical Inc has signed a collaboration agreement with Mimic Technologies to deliver simulation modules for its sport robotic surgical system.

The simulation systems will enable the company to develop a surgeon training programme for the surgical system.

Based in Canada, Titan Medical is a medical device company, while Mimic Technologies is a US-based developer of robotic surgery simulation.

RxFunction Inc has raised $7.5m through a series A financing round led by Cedar Point Capital LLC.

The company plans to use the proceeds towards FDA registration and funding the next clinical trial in the US. The funds will also be used for commercialisation of products.

Based in the US, RxFunction is a developer and manufacturer of wearable sensory prosthesis, while Cedar Point, also based in the US, is an investment company.